Amarin Corp Plcuk (AMRN) Interest Coverage Ratio (2010 - 2026)
Amarin Corp Plc\Uk (AMRN) posted quarterly Interest Coverage Ratio of 1.36 for Q2 2026, down 3.59% year-over-year from 1.41 in Q2 2025, and down 14.81% quarter-over-quarter from 1.18 in Q1 2026.
Amarin Corp Plcuk (AMRN) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Amarin Corp Plc\Uk (AMRN) has reported Interest Coverage Ratio for 17 consecutive years, with 1.36 the latest figure, recorded in Q2 2026.
- In Q2 2026, Interest Coverage Ratio fell 3.59% year-over-year to 1.36; the TTM figure through Jun 2026 stood at 4.61 (up 49.09% YoY), while the FY2025 annual figure was 0.29, up 41.03% from the prior year.
- Interest Coverage Ratio slipped to 1.36 in Q2 2026 per AMRN's latest filing, from 1.18 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.03 in Q4 2023 and bottomed at 9.79 in Q4 2025.
- Historically, Interest Coverage Ratio has averaged 1.6 across 5 years, with a median of 1.22 in 2025.
- Annual changes were most pronounced in 2024 — Interest Coverage Ratio jumped 97.34% — and 2025, when it slumped 3396.48%.
- Amarin Corp Plc\Uk's Interest Coverage Ratio stood at 0.06 in 2022, then jumped by 51.43% to 0.03 in 2023, then plunged by 894.55% to 0.28 in 2024, then plunged by 3396.48% to 9.79 in 2025, then surged by 86.13% to 1.36 in 2026.
- Business Quant data shows AMRN's Interest Coverage Ratio at 1.36 in Q2 2026, 1.18 in Q1 2026, and 9.79 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 651.33 Bn | 630.58 Bn | 17.26 Bn | 25.41 |
| 2 | AbbVie | 469.67 Bn | 463.10 Bn | 12.70 Bn | - |
| 3 | Merck | 374.13 Bn | 366.99 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 302.76 Bn | 295.07 Bn | 11.24 Bn | 10.28 |
| 5 | Astrazeneca | 257.15 Bn | 252.25 Bn | 12.86 Bn | 7.27 |
| 6 | Amgen | 236.76 Bn | 222.77 Bn | 7.24 Bn | 5.22 |
| 7 | Gilead Sciences | 182.54 Bn | 179.36 Bn | 6.22 Bn | -42.08 |
| 8 | Pfizer | 159.57 Bn | 147.87 Bn | 10.94 Bn | - |
| 9 | Gsk | 105.99 Bn | 101.83 Bn | 8.24 Bn | -2.64 |
| 10 | Amarin Corp Plcuk | 5.89 Bn | 5.58 Bn | 14.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.36 |
| Mar 31, 2026 | -1.18 |
| Dec 31, 2025 | -9.79 |
| Sep 30, 2025 | -0.97 |
| Jun 30, 2025 | -1.31 |
| Mar 31, 2025 | -1.26 |
| Dec 31, 2024 | -0.28 |
| Sep 30, 2024 | -1.87 |
| Jun 30, 2024 | -0.04 |
| Mar 31, 2024 | -0.98 |
| Dec 31, 2023 | -0.03 |
| Sep 30, 2023 | -1.41 |
| Jun 30, 2023 | -1.49 |
| Mar 31, 2023 | -1.04 |
| Dec 31, 2022 | -0.06 |
| Sep 30, 2022 | -0.31 |
| Jun 30, 2022 | -3.71 |
| Mar 31, 2022 | -1.63 |
| Dec 31, 2021 | 0.10 |
| Sep 30, 2021 | -0.78 |